Released Feb 28, 2023, after the close
10-K filed Feb 28, 2023, 59 days after period end · 0001636422-23-000033
Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$69.16M$69.16M derived+6.9% vs Q4 2021+1.2% vs Q3 2022
Net Income-$35.78M-$35.78M derivedN/M vs Q4 2021N/M vs Q3 2022
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$36,745,000N/M
Operating Cash Flowderived-$14,821,000N/M
Free Cash Flowderived-$15,236,000N/M
Margins · derived
Operating margin-53.1%+16.0 pt vs Q4 2021
Net margin-51.7%+24.0 pt vs Q4 2021
What the release said
The release
Same quarter
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $69.16M | $64.72M | $53.28M | $43.50M |
| Net Income | -$35.78M | -$48.99M | -$43.02M | -$14.27M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR